Cadila Pharmaceuticals-backed IRM Energy., raised Rs 545.40 crore through a fresh share sale, issuing 1.08 crore shares. The company, focused on developing Natural Gas distribution projects nationwide for industrial, commercial and domestic customers, made a subdued debut on the stock exchanges. The weak listing performance was attributed primarily to the prevailing negative sentiment in the market on its listing day. The company experienced a decline in annual net profits, decreasing from Rs 113 crore in FY22 to Rs 56 crore in FY23.